Cite Filings / AKTS
Feed Companies Filings Check
Sign in

CIK 0002035832

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Aktis Oncology, Inc.

Sign in to watch
Ticker
AKTS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
852584233
Phone
+1 978-237-4380
Business address
17 DRYDOCK AVENUE, SUITE #17-401, BOSTON, MA, 02210
Filings Financials Insiders Search text
All 71 Financials 10 Executive Compensation 7 Insider Trading 30 Beneficial Ownership Interest 6 Business Combinations 6 Public Offerings 8 Others 17
›
Filed in
  1. No filings match these filters. Clear filters
  2. 3 Insider Initial Statement of Ownership 2026-01-08
  3. 3 Insider Initial Statement of Ownership 2026-01-08
  4. 3 Insider Initial Statement of Ownership 2026-01-08
  5. 3 Insider Initial Statement of Ownership 2026-01-08
  6. 3 Insider Initial Statement of Ownership 2026-01-08
  7. 3 Insider Initial Statement of Ownership 2026-01-08
  8. 3 Insider Initial Statement of Ownership 2026-01-08
  9. 3 Insider Initial Statement of Ownership 2026-01-08
  10. 3 Insider Initial Statement of Ownership 2026-01-08
  11. 3 Insider Initial Statement of Ownership 2026-01-08

Page 2 of 2 · 30 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…